premargin

9527 Ratios - AME Company for Medical Supplies | premargin

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Market & Price
Market Capitalization	657.65M	886.20M	351.40M	244.30M	—
Market Cap Growth	-36.9%	+152.2%	+43.8%	—	—
Enterprise Value	659.13M	879.01M	327.70M	238.46M	—
Last Close Price	93.95	124.29	47.63	31.73	—
Valuation Multiples
PE Ratio	14.08	19.52	10.49	9.16	—
PS Ratio	2.38	3.57	1.60	1.27	—
PB Ratio	3.82	5.58	2.76	2.28	—
P/TBV Ratio	3.87	5.63	2.76	2.28	—
P/FCF Ratio	67.99	—	10.12	32.33	—
P/OCF Ratio	63.34	—	9.59	29.19	—
EV/Sales Ratio	2.38	3.54	1.49	1.23	—
EV/EBITDA Ratio	12.17	17.56	8.80	7.95	—
EV/EBIT Ratio	12.55	17.82	8.90	8.02	—
EV/FCF Ratio	68.15	—	9.44	31.56	—
Leverage & Capital
Debt / Equity Ratio	0.29	0.01	0.02	0.01	0.02
Debt / EBITDA Ratio	0.93	0.03	0.07	0.04	0.06
Debt / FCF Ratio	5.18	—	0.08	0.15	0.08
Net Debt / Equity Ratio	0.01	-0.14	-0.32	-0.21	-0.29
Net Debt / EBITDA Ratio	0.03	-0.45	-1.10	-0.74	-1.10
Net Debt / FCF Ratio	0.15	5.79	-1.18	-2.94	-1.35
Efficiency & Liquidity
Asset Turnover	1.11	1.18	1.28	1.34	1.28
Inventory Turnover	2.54	2.46	2.73	2.88	3.48
Quick Ratio	1.75	2.46	2.54	2.69	3.06
Current Ratio	2.59	3.77	3.53	4.06	4.10
Returns & Yields
Return on Equity (ROE)	+30.0%	+31.7%	+28.6%	+26.6%	+27.0%
Return on Assets (ROA)	+13.1%	+14.7%	+13.4%	+12.9%	+12.9%
Return on Invested Capital (ROIC)	+30.8%	+40.2%	+38.3%	+34.8%	+35.7%
Return on Capital Employed (ROCE)	+28.0%	+28.9%	+26.7%	+25.4%	+24.0%
Earnings Yield	+7.1%	+5.1%	+9.5%	+10.9%	—
FCF Yield	+1.5%	-0.4%	+9.9%	+3.1%	—
Dividend Yield	+2.1%	+1.6%	+4.2%	+6.3%	—
Payout Ratio	+29.9%	+30.8%	+41.7%	+45.9%	+7.5%
Buyback Yield / Dilution	—	—	—	-0.6%	-21.2%
Total Shareholder Return	+2.1%	+1.6%	+4.2%	+5.7%	-21.2%